If PPHM ran a meaningful trial, it would risk having it show that Bavituximab doesn’t work so well. Then the game would be over and the executives might be out of a job.
In short, I wouldn’t hold my breath waiting for PPHM to run a meaningful trial. More likely, PPHM will seek to build on its World Record for running meaningless ones.
p.s. I know that you know all this—the post is for the benefit of those who might not.
Market Data 
Markets 
AI
